To start selling GLP-1 you need three pieces in place: a licensed Provider to write prescriptions, a licensed compounding pharmacy to fill them, and a compliant signup flow that screens patients before any medication ships. A turnkey platform bundles all three, which is why you can sell under your own brand without a medical license.
The demand is already proven. More than 40% of American adults have obesity, according to the Centers for Disease Control and Prevention. Brand-name semaglutide retails between $900 and $1,500 per month without insurance, which prices most of that population out. Compounded semaglutide typically runs $150 to $350 per month for the medication itself, and that price gap is what created the cash-pay market this guide covers. Patients who cannot get coverage or afford the brand name are buying compounded GLP-1 through programs that price it like a subscription.
This guide is for the business owners capturing that demand: med spa and salon owners with foot traffic, gym owners with members, estheticians and chiropractors with customer lists, and entrepreneurs and creators with an audience. Your job in this business is selling. The clinical work belongs to licensed Providers, the manufacturing belongs to licensed pharmacies, and the compliance structure sits underneath all of it. What follows is the full path from legal setup to first paying patients, including the acquisition funnel, the signup flow, the first 30 days, and the revenue math.
Is selling GLP-1 legal for you?
The structure that makes this legal for a non-clinical owner is the management services organization (MSO) model. Your company is a management and marketing business. Every prescription is written by a state-licensed Provider, either one you bring or one sourced from the platform’s Provider Network. If you are a licensed prescriber yourself, you can write prescriptions under your own authority. If not, the network covers clinical decisions across all 50 states. You run the business. Providers make the clinical decisions. That separation is the legal foundation of cash-pay telehealth, and it is why a gym owner or esthetician can own a weight loss brand.
What the platform provides is the infrastructure around that separation: access to the Provider Network, integration with licensed compounding pharmacies, and the signup flow that sits between a buyer and a prescription. The GLP-1 weight loss platform page breaks down exactly what a partner owns versus what the platform handles.
The commercial structure is cash-pay, which keeps the business simple. You collect payment directly from the patient, there is no insurance claim process, and the price is whatever you set. That is the same transaction pattern as a gym membership or a treatment package, which is why it fits the skill set of a business owner.
One regulatory note: compounded GLP-1 availability is tied to FDA shortage status. The FDA declared the semaglutide shortage resolved in early 2025 and started a wind-down period, court challenges from compounding industry groups have kept the rules in flux, and tirzepatide’s status has shifted over the same period. The current GLP-1 compounding regulations guide tracks what changed. Your job as the seller is not to interpret the FDA docket; it is to operate through licensed partners who do. This article is business guidance, not legal advice, and any serious launch should be reviewed by counsel.
Step 1: Set up your brand and compliance
The setup is a business entity, a brand, and a compliant payment path. Register the company, an LLC being the standard vehicle. Pick the brand name, secure the domain, and put your signup page on a subdomain that carries your name. The platform handles the white-labeling so patients see your brand at every step, never the platform’s.
The compliance reality that surprises most first-time sellers is payment processing. Visa and Mastercard require LegitScript certification for telehealth merchants in certain merchant categories, and Google and Meta require it for advertising. An uncertified business faces declined transactions, account reserves, or sudden terminations. The LegitScript certification guide walks through the requirements and the application process. A full clinic build-out bundles this certification work, so you do not sit through a lengthy application while patients wait. Before you commit to any platform, run it through the questions to ask before choosing a GLP-1 platform.
Setup is not the bottleneck, and this is where the turnkey model changes the timeline. White-label brands go live the same day, with setup typically taking about 20 minutes once your branding assets are ready. Most telehealth platforms take 60 days or more. The reason is simple: the Provider Network, pharmacy integrations, and signup flow already exist, so the remaining work is your brand, your pricing, and your marketing. The real bottleneck is patient acquisition, which is step 2.
Step 2: Build your patient acquisition funnel
GLP-1 buyers come from three channels: the customers you already have, local demand, and your social or creator audience. Most new programs underestimate the first one.
A med spa with 200 customers a week has an audience that already trusts it with their appearance and health. Weight loss is the most requested program in this category, so the signup conversation starts with people who are already in the door. Even a 1% enrollment rate across a few hundred customers per month produces several new patients, and each one carries recurring monthly margin. Gyms have the same dynamic with members who train hard but cannot move the scale. Salons, chiropractors, and estheticians all have customer lists that map to the same conversation.
Local demand and social channels fill in from there. Local search captures people searching for weight loss programs in your city. A creator with 100,000 followers does not need a strong conversion rate: 1% clicking through is 1,000 visits, and a small fraction of those visits turning into signups produces a patient base within months. For a brick-and-mortar owner, the funnel is a menu item plus a signup page. For a creator, it is a link in the bio.
The signup page is your storefront, and it should do three things: state what the program is, state what it costs monthly, and collect the signup. You set the pricing, and $399 per month is a common midpoint for white-label GLP-1 programs. The page runs under your brand, and the medication ships to the patient’s door, so the transaction reads like a membership with your brand. The guide to launching a GLP-1 weight loss business covers the market and business model in more depth if you want the full picture before you build.
Step 3: Turn inquiries into patients
Once someone clicks, the platform runs the clinical flow while you run the follow-up. The patient completes a short signup covering health history and weight loss goals. An automated eligibility screen checks for disqualifying conditions before any prescription is written, so a patient who will never qualify is told early instead of burning a provider consult. A licensed Provider reviews the case and, if approved, the pharmacy ships the medication. The whole sequence happens in days, not weeks.
All of it runs under your brand, which is the point of the white-label model. The white-label GLP-1 brand guide walks through what you own in that arrangement: the patient relationship, the pricing, and the margin.
Three conversion tactics move the numbers more than anything else. Answer inquiries within hours, because the buyer who is researching GLP-1 today is deciding today. Put the price on the page, because surprise pricing kills more enrollments than high pricing does. And lead with outcomes, because patients are buying results. They respond to what the program does, not to the mechanism behind it. Keep the signup to one sitting and follow up with anyone who starts but stalls.
You never touch the clinical work. That is the design of the model: you sell, Providers decide, pharmacies ship, and the patient relationship stays yours.
Step 4: The first 30 days
Expect the first patients in the first two weeks if you are routing an existing audience to the funnel. Onboarding is straightforward: welcome message, first shipment, and clear expectations about the timeline, because GLP-1 results build over weeks rather than days. Automated check-ins handle the ongoing communication so you are not personally texting every patient.
The refill cadence is what makes this a subscription business. Patients receive medication monthly, refills run automatically inside the prescription period, and a new provider review is required when a prescription period ends. Revenue is recurring by design, not by hope.
The cash flow is clean: the patient pays you, you pay pass-through costs for medication and provider consults, and you keep the margin. Because you set the pricing, the margin is a decision you make, not a number handed to you. The platform charges a monthly fee, so growing from 10 patients to 50 does not multiply your platform cost.
The compounding effect shows up around weeks 4 to 8, when patients start seeing visible results. That is when word-of-mouth begins and when most programs either lock patients in or lose them. Programs that check in during that window keep patients past the dropout point, and a retained patient is worth months of recurring margin. Measure the funnel from day one: how many people land on the page, how many start signup, how many complete it, and how many stay past week 4. That conversion line is the operating report for this business.
Revenue and scale math
The economics are subscription-shaped, which makes them predictable. A program priced at $399 per month, a common midpoint for white-label brands, typically nets $250 or more per patient per month after medication and provider costs.
The revenue ladder is linear. Ten patients is roughly $2,500 per month. Thirty patients is $7,500 per month. One hundred patients is $25,000 per month. Programs that launch with an existing audience commonly reach 20 to 30 patients in the first month, which is $5,000 to $7,500 per month before a dollar is spent on paid ads. The cash-pay revenue model breakdown goes deeper into what practices actually earn across GLP-1 and peptide programs.
The demand floor is structural. More than 40% of American adults have obesity, and brand-name medication at $900 to $1,500 per month leaves most of them priced out of the branded channel. The global GLP-1 market generated $58.40 billion in revenue in 2025 and is projected to reach $212.73 billion by 2035, a 13.8% compound annual growth rate, according to Precedence Research. The channel that captures the price-sensitive majority of that market is cash-pay compounded programs, and the operators who capture it are the ones who already have trust: the med spas, gyms, and creators who treat it as a distribution business.
Selling GLP-1 is a distribution business. Build the brand, run the funnel, convert the inquiries, and let the clinical infrastructure do the clinical work. The first patients come from the audience you already have, and the revenue compounds from there.
Book a call with Karpa Health to walk through the launch, from compliance setup to your first paying patients.
